ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO1086

Sex Differences in Probable Dementia and Mild Cognitive Impairment in CKD and Non-CKD: The SPRINT MIND Randomized Clinical Trial

Session Information

Category: CKD (Non-Dialysis)

  • 2301 CKD (Non-Dialysis): Epidemiology, Risk Factors, and Prevention

Authors

  • Oh, Ester, University of Colorado Anschutz Medical Campus School of Medicine, Aurora, Colorado, United States
  • You, Zhiying, University of Colorado Anschutz Medical Campus School of Medicine, Aurora, Colorado, United States
  • Brunt, Vienna E., University of Colorado Anschutz Medical Campus School of Medicine, Aurora, Colorado, United States
  • Chonchol, Michel, University of Colorado Anschutz Medical Campus School of Medicine, Aurora, Colorado, United States
  • Nowak, Kristen L., University of Colorado Anschutz Medical Campus School of Medicine, Aurora, Colorado, United States
Background

Females have higher risk of cognitive decline as compared to males in the general population. However, little is known whether this sex-specific risk pattern of cognitive decline translates to individuals with chronic kidney disease (CKD). This study examined sex differences in the risk of cognitive decline in older adults with elevated blood pressure and at high risk of cardiovascular events, who participated in the Systolic Blood Pressure Intervention Trial Memory and Cognition IN Decreased Hypertension (SPRINT MIND) study, both with and without CKD.

Methods

A Cox proportional hazard model was used to compare sex differences in the risk of incident cognitive outcomes (probable dementia [PD], mild cognitive impairment [MCI]; and their composite) in males and females matched for propensity scores (based on age, race, education, randomization arm, smoking status, cardiovascular disease history systolic blood pressure, body-mass index, and estimated glomerular filtration rate [eGFR]), separately for those without and with CKD (defined as eGFR 20-59 ml/min/1.73m2).

Results

Adults without CKD (n=2,506; 50% F; mean±SD age 68±9 y; eGFR 81±16 ml/min/1.73m2) and with CKD (n=1,362; 50% F; 70±9 y; eGFR 49±10 ml/min/1.73m2) were included in the study. The median (IQR) follow-up was 4.6 years (3.6-5.9) and 4.1 years (3.3-5.9) for the non-CKD and CKD groups, respectively. In adults without CKD, there were no sex differences in the risk of MCI/PD composite or PD. Males without CKD had higher MCI risk than females (Figure A). Males with CKD had higher risk of MCI/PD composite and PD than females (Figure B). Additionally, MCI risk in males with CKD tended to be higher than females.

Conclusion

Males with CKD had a higher risk of PD than females; this sex difference in the risk of dementia was not observed in participants without CKD.

Figure. Sex differences in the risk of PD/MCI composite, PD, and MCI in adults without CKD (A) and with CKD (B).

Funding

  • Private Foundation Support